Skip to content
Screener

Kalaris Therapeutics KLRS Q2 2025 earnings

Reported August 13, 2025 · Before market open

EPS-$0.61Miss by $0.10
EPS estimate-$0.51

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.52

Financials

Q2 2025

Income statement

See full
Operating income-$12.3M-193%
Net income-$11.4M-101%
EPS (diluted)-$0.61+85.7%

Balance sheet

See full
Cash & equivalents$88.4M+1,317%
Total equity$53.1M+203%
Total assets$92.8M-29.1%

Cash flow

See full
Operating cash flow-$12.5M-216%

FAQ

When did Kalaris Therapeutics report Q2 2025 earnings?
Kalaris Therapeutics (KLRS) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Kalaris Therapeutics's Q2 2025 revenue and EPS?
Kalaris Therapeutics reported eps of $-0.61 for Q2 2025.
Did Kalaris Therapeutics beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.51 by $0.10.
How did Kalaris Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 46.2% from $-1.13.
Where can I find Kalaris Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-179466) and the 10-Q periodic report (0000950170-25-107979) directly on SEC EDGAR. The filing index links above go to sec.gov.